Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer

The emergence of immune checkpoint inhibitors (ICIs) has reshaped the landscape of advanced lung cancer treatment. The brain is the most common metastatic site for lung cancer. Whether conventional criteria can evaluate the intracranial response of ICIs remains unclear. Here, we report a well-docume...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Lishui, Li, Xiang, Meng, Li, Zhang, Yingying, Wan, Xin, Jing, Di, Zhou, Qin, Zhou, Rongrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752014/
https://www.ncbi.nlm.nih.gov/pubmed/36532056
http://dx.doi.org/10.3389/fimmu.2022.1064596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752014/
https://www.ncbi.nlm.nih.gov/pubmed/36532056
http://dx.doi.org/10.3389/fimmu.2022.1064596

Ejemplares similares